Source comparison
Thymalin vs Thymosin Alpha-1: Research Comparison
Molecular Structure Polypeptide complex, 10–15 kDa, extracted from calf thymus Synthetic 28-amino-acid acetylated peptide, 3,108 Da Thymalin is biological extract; Thymosin Alpha-1 is defined synthetic sequence Primary Mechanism Restores thymic epithelial cell
This comparison does not assign a generated winner or score.
- Molecular Structure
- Polypeptide complex, 10–15 kDa, extracted from calf thymus
- Synthetic 28-amino-acid acetylated peptide, 3,108 Da
- Thymalin is biological extract; Thymosin Alpha-1 is defined synthetic sequence
- Primary Mechanism
- Restores thymic epithelial cell function and T-cell differentiation in thymus
- Binds TLR-2/TLR-9 on dendritic cells, upregulates IL-2/IFN-gamma, skews Th1 response
- Thymalin acts on tissue architecture; Thymosin Alpha-1 acts on receptor signaling
- Half-Life
- 6–8 hours
- 2 hours
- Thymalin allows less frequent dosing; Thymosin Alpha-1 requires timing precision
- Ideal Research Models
- Immune senescence, thymic involution, post-chemotherapy recovery, autoimmune rebalancing
- Antiviral immunity, vaccine adjuvant, cancer immunotherapy, acute infection models
- Choose based on upstream (Thymalin) vs downstream (Thymosin Alpha-1) intervention point
- Standard Dosing
- 5–20 mg SC every 48–72 hours
- 1.6–6.4 mg SC twice weekly
- Both subcutaneous; Thymalin broader dose range reflects polypeptide variability
- Effect on Thymic Architecture
- Increases thymic cortex thickness, FOXN1 expression, TREC counts
- No effect on thymus structure or naïve T-cell output
- Only Thymalin regenerates thymic tissue. Validated by histology
- Effect on Cytokine Profile
- Mild increase in IL-2, restores Treg populations
- Strong upregulation of IFN-gamma, IL-12; suppresses IL-4, IL-10
- Thymosin Alpha-1 creates Th1-dominant shift; Thymalin balances without skewing
- Injection Site Tolerability
- 10–15% mild inflammation (bovine peptide recognition)
- <5% reactions (fully synthetic, human sequence)
- Thymosin Alpha-1 better tolerated in repeated-dose protocols
- Post-Reconstitution Stability
- 14 days at 2–8°C
- 28 days at 2–8°C
- Thymosin Alpha-1's acetylation extends shelf life after mixing